Tabula Rasa HealthCare
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Tabula Rasa HealthCare sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Tabula Rasa HealthCare: 5 sponsored US clinical trials, none currently recruiting.
Tabula Rasa HealthCare sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. The most-studied condition in this pipeline is Pharmacogenomics, with 1 trials.
Upper-quartile sponsor footprint
Tabula Rasa HealthCare sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Type 2 Diabetes With Antiplatelet Drugs
NCT05053828
LACE+ and MRS Score Readmission Rate Assessment
NCT04365673
Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy
NCT04339634
The Use of Antipsychotics in the Program of All-inclusive Care for the Elderly (PACE)
NCT03692182
Implementation Study of Enhanced Medication Therapy Management in Primary Care Practice
NCT02748148
Therapeutic Areas
How the Tabula Rasa HealthCare archive is shaped
5 indexed studies, none listed as recruiting (0% open); 4 completed (80%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Pharmacogenomics (1 trial), 5 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Tabula Rasa HealthCare: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Tabula Rasa HealthCare sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Tabula Rasa HealthCare page
5 registered trials is a research-attention snapshot, not an endorsement of Tabula Rasa HealthCare or any single study.
- None of Tabula Rasa HealthCare's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Pharmacogenomics is the condition Tabula Rasa HealthCare studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pharmacogenomics trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Tabula Rasa HealthCare pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.